Product Name: Klow
Type: Multi-Peptide Research Blend

Compound Composition:

• GHK-Cu – 50 mg
• TB-500 – 10 mg
• BPC-157 – 10 mg
• KPV – 10 mg

Research Focus:

KLOW is a multi-peptide blend combining TB-500 (10 mg), BPC-157 (10 mg), KPV (10 mg), and GHK-Cu (50 mg) for a total of 80 mg per vial. TB-500 (synthetic thymosin beta-4) promotes wound healing, angiogenesis, and tissue repair[1][2]. BPC-157 exhibits regenerative properties with preclinical evidence supporting tendon, ligament, and muscle healing[3][4]. KPV is an anti-inflammatory tripeptide that modulates NF-κB signaling[5][6]. GHK-Cu supports collagen synthesis, wound healing, and tissue regeneration[7][8]. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Research Interest:

• Inflammatory signaling pathway research

• Tissue recovery and repair models

• Immune-cell interaction studies

• Chronic stress and regeneration signaling

Scientific Interest:

• Multi-pathway inflammatory response networks

• Cellular repair and extracellular matrix signaling

• Immune-modulated tissue recovery models

Reconstitution:

• Reconstitute: Add 3.0 mLbacteriostatic water → ~26.7 mg/mLtotal concentration.

• Component concentrations: TB-500, BPC-157, KPV each at ~3.33 mg/mL; GHK-Cu at ~16.7 mg/mL.

• Easy measuring: At 26.7 mg/mL total, 1 unit = 0.01 mL ≈ 267 mcg total peptideon a U-100 insulin syringe.

• Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Cycle:

Standard / Gradual Approach (3 mL = ~26.7 mg/mL Total)

This multi-peptide blend provides synergistic regenerative, anti-inflammatory, and tissue-repair support. The following titration schedule allows gradual introduction of each component.

Frequency: Inject once dailysubcutaneously. This schedule uses a 3.0 mL dilution to maintain measurable volumes. For ≤10-unit (≤0.10 mL) administrations during initial weeks, consider 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

1. Draw 3.0 mL bacteriostatic water with a sterile syringe.

2. Inject slowly down the vial wall; avoid foaming.

3. Gently swirl/roll until dissolved (do not shake).

4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Syringe Math Reference

With 3.0 mL reconstitution volume and 80 mg total peptide:

• Total concentration: 26.67 mg/mL (26,667 mcg/mL)

• TB-500: 3.33 mg/mL → 33.3 mcg per unit

• BPC-157: 3.33 mg/mL → 33.3 mcg per unit

• KPV: 3.33 mg/mL → 33.3 mcg per unit

• GHK-Cu: 16.67 mg/mL → 166.7 mcg per unit

• 1 unit (0.01 mL) = 33.3 mcg each of TB-500, BPC-157, KPV + 166.7 mcg GHK-Cu

IMPORTANT NOTICE:

This product is intended strictly for laboratory research. It is not intended to diagnose, treat, cure, or prevent any disease.